Cheesman M, Ilanko A, Blonk B, Cock I
Pharmacogn Rev. 2017; 11(22):57-72.
PMID: 28989242
PMC: 5628525.
DOI: 10.4103/phrev.phrev_21_17.
Fadlallah A, Chelala E, Legeais J
Open Ophthalmol J. 2016; 9:167-8.
PMID: 26862360
PMC: 4740968.
DOI: 10.2174/1874364101509010167.
Sievert D, Wilson M, Wilkins M, Gillespie B, Boulton M
Am J Public Health. 2010; 100(9):1777-83.
PMID: 20634456
PMC: 2920987.
DOI: 10.2105/AJPH.2009.181958.
Wichelhaus T, Schulze J, Hunfeld K, Schafer V, Brade V
Eur J Clin Microbiol Infect Dis. 1998; 16(12):893-7.
PMID: 9495669
DOI: 10.1007/BF01700555.
Adachi Y, Nakamura K, Kato Y, Hazumi N, Hashizume T, Nakagawa S
Antimicrob Agents Chemother. 1997; 41(10):2282-5.
PMID: 9333063
PMC: 164108.
DOI: 10.1128/AAC.41.10.2282.
Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
Sumita Y, Nouda H, Kanazawa K, Fukasawa M
Antimicrob Agents Chemother. 1995; 39(4):910-6.
PMID: 7785994
PMC: 162652.
DOI: 10.1128/AAC.39.4.910.
Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.
Frongillo R, Bianchi P, Moretti A, Pasticci M, Ripa S, PAULUZZI S
Antimicrob Agents Chemother. 1984; 25(5):666-8.
PMID: 6563877
PMC: 185613.
DOI: 10.1128/AAC.25.5.666.
Common bacterial pathogens and resistance to antibiotics.
Sanderson P
Br Med J (Clin Res Ed). 1984; 289(6446):638-9.
PMID: 6434019
PMC: 1443134.
DOI: 10.1136/bmj.289.6446.638.
Antibacterial activity of coumermycin alone and in combination with other antibiotics.
Neu H, Chin N, Labthavikul P
Antimicrob Agents Chemother. 1984; 25(6):687-9.
PMID: 6331295
PMC: 185623.
DOI: 10.1128/AAC.25.6.687.
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Guenthner S, Wenzel R
Antimicrob Agents Chemother. 1984; 26(2):268-9.
PMID: 6237606
PMC: 284135.
DOI: 10.1128/AAC.26.2.268.
Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus.
Meyers B, Srulevitch E, Hirschman S
Antimicrob Agents Chemother. 1985; 28(5):706-7.
PMID: 3853964
PMC: 176365.
DOI: 10.1128/AAC.28.5.706.
Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin.
Van der Auwera P, Klastersky J
Antimicrob Agents Chemother. 1986; 30(6):892-5.
PMID: 3813515
PMC: 180614.
DOI: 10.1128/AAC.30.6.892.
Epidemiologic study of Staphylococcus strains isolated from clinical material in 24 Italian hospitals.
Varaldo P
Eur J Epidemiol. 1986; 2(3):208-14.
PMID: 3792518
DOI: 10.1007/BF00211534.
In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.
Lau W, TEOH-CHAN C, Fan S, Lau K
J Hyg (Lond). 1986; 96(3):419-23.
PMID: 3637200
PMC: 2129703.
DOI: 10.1017/s0022172400066183.
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains.
Frongillo R, Donati L, Federico G, Martino P, Moroni M, ORTONA L
Antimicrob Agents Chemother. 1986; 29(5):789-96.
PMID: 3637066
PMC: 284155.
DOI: 10.1128/AAC.29.5.789.
In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
ELWELL L, Wilson H, Knick V, Keith B
Antimicrob Agents Chemother. 1986; 29(6):1092-4.
PMID: 3488022
PMC: 180506.
DOI: 10.1128/AAC.29.6.1092.
Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.
Smith S, Eng R
Antimicrob Agents Chemother. 1985; 27(5):688-91.
PMID: 3160301
PMC: 180133.
DOI: 10.1128/AAC.27.5.688.
Antimicrobial resistance of Staphylococcus aureus: genetic basis.
Lyon B, Skurray R
Microbiol Rev. 1987; 51(1):88-134.
PMID: 3031442
PMC: 373094.
DOI: 10.1128/mr.51.1.88-134.1987.
Immunoblots, antimicrobial resistance, and bacteriophage typing of oxacillin-resistant Staphylococcus aureus.
Mulligan M, Kwok R, Citron D, John Jr J, Smith P
J Clin Microbiol. 1988; 26(11):2395-401.
PMID: 2976772
PMC: 266900.
DOI: 10.1128/jcm.26.11.2395-2401.1988.
Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin.
Van der Auwera P, Klastersky J
Antimicrob Agents Chemother. 1987; 31(7):1002-5.
PMID: 2959197
PMC: 174860.
DOI: 10.1128/AAC.31.7.1002.
